Robert E. Gagnon - 22 May 2025 Form 4 Insider Report for Verastem, Inc. (VSTM)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
27 May 2025, 17:45:25 UTC
Prior SEC filing
19 Mar 2025
Next SEC filing
06 Jun 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel Calkins, Attorney in Fact

Key filing fact

Robert E. Gagnon filed Form 4 for Verastem, Inc. (VSTM) on 27 May 2025.

Key facts

  • This page summarizes Robert E. Gagnon's Form 4 filing for Verastem, Inc. (VSTM).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 May 2025, 17:45.

Change

  • Previous filing in this sequence was filed on 19 Mar 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001504983 Primary reporting owner

Gagnon Robert E.

Relationship
Director
Address
C/O VERASTEM, INC.,, 117 KENDRICK ST., SUITE 500, NEEDHAM
Signature
/s/ Daniel Calkins, Attorney in Fact
Signature date
27 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VSTM transaction

Common Stock

Award

Transaction value
$0
Shares
+8,333
Change %
+24%
Price
$0.000000
Shares after
42,526
Date
22 May 2025
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VSTM transaction Derivative

Stock Option (right to buy)

Award

Transaction value
$0
Shares
+12,500
Change %
Price
$0.000000
Shares after
12,500
Date
22 May 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
12,500
Exercise price
$7.48
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2025 to April, 2026 and the last installment shall vest on the earlier of (i) the day before the 2026 Annual Meeting of Stockholders is held or (ii) May 31, 2026, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date.

Footnote F2

The stock option vests in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2025 to April, 2026 and the last installment shall vest on the earlier of (i) the day before the 2026 Annual Meeting of Stockholders is held or (ii) May 31, 2026, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .